- Home
- ATOS vs OFS Comparison
ATOS vs OFS Comparison
Compare ATOS & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATOS | OFS |
|---|---|---|
| Founded | 2009 | 2001 |
| Country | United States | United States |
| Employees | 14 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.4M | 54.3M |
| IPO Year | 2010 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ATOS | OFS |
|---|---|---|
| Price | $2.27 | $3.57 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $18.67 | N/A |
| AVG Volume (30 Days) | 47.2K | ★ 71.1K |
| Earning Date | 11-11-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 18.76% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,758.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.53 | $2.72 |
| 52 Week High | $7.56 | $7.81 |
Technical Indicators
Market Signals| Indicator | ATOS | OFS |
|---|---|---|
| Relative Strength Index (RSI) | 42.33 | 43.87 |
| Support Level | $2.05 | $3.53 |
| Resistance Level | $2.60 | $4.00 |
| Average True Range (ATR) | 0.15 | 0.13 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 39.17 | 13.04 |
Price Performance
Historical ComparisonAbout ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to provide its stockholders with both current income and capital appreciation through debt investments and, to a lesser extent, equity investments.